Literature DB >> 18485925

Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties.

Larra M Yuelling1, Babette Fuss.   

Abstract

Recent studies have established that autotaxin (ATX), also known as phosphodiesterase Ialpha/autotaxin (PD-Ialpha/ATX) or (ecto)nucleotide pyrophosphatase/phosphodiesterase 2 [(E)NPP2], represents a multi-functional and multi-modular protein. ATX was initially thought to function exclusively as a phosphodiesterase/pyrophosphatase. However, it has become apparent that this enzymatically active site, which is ultimately responsible for ATX's originally discovered property of tumor cell motility stimulation, mediates the conversion of lysophosphatidylcholine (LPC) to lysophosphatidic acid (LPA). In addition, a separate functionally active domain, here referred to as the Modulator of Oligodendrocyte Remodeling and Focal adhesion Organization (MORFO) domain, was discovered in studies analyzing the role of ATX during the differentiation of myelinating cells of the central nervous system (CNS), namely oligodendrocytes. This novel domain was found to mediate anti-adhesive, i.e. matricellular, properties and to promote morphological maturation of oligodendrocytes. In this review, we summarize our current understanding of ATX's structure-function domains and discuss their contribution to the presently known main functional roles of ATX.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18485925      PMCID: PMC2564869          DOI: 10.1016/j.bbalip.2008.04.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  98 in total

Review 1.  Adhesion assembly, disassembly and turnover in migrating cells -- over and over and over again.

Authors:  Donna J Webb; J Thomas Parsons; Alan F Horwitz
Journal:  Nat Cell Biol       Date:  2002-04       Impact factor: 28.824

2.  Secretion and lysophospholipase D activity of autotaxin by adipocytes are controlled by N-glycosylation and signal peptidase.

Authors:  Jean Philippe Pradère; Evelyne Tarnus; Sandra Grès; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  Biochim Biophys Acta       Date:  2006-12-06

3.  Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.

Authors:  Dominique B Hoelzinger; Luigi Mariani; Joachim Weis; Tanja Woyke; Theresa J Berens; Wendy S McDonough; Andrew Sloan; Stephen W Coons; Michael E Berens
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

4.  Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma.

Authors:  N E Savaskan; L Rocha; M R Kotter; A Baer; G Lubec; L A van Meeteren; Y Kishi; J Aoki; W H Moolenaar; R Nitsch; A U Bräuer
Journal:  Cell Mol Life Sci       Date:  2007-01       Impact factor: 9.261

5.  GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.

Authors:  Chang-Wook Lee; Richard Rivera; Shannon Gardell; Adrienne E Dubin; Jerold Chun
Journal:  J Biol Chem       Date:  2006-06-14       Impact factor: 5.157

6.  Molecular cloning, expression, and localization of a brain-specific phosphodiesterase I/nucleotide pyrophosphatase (PD-I alpha) from rat brain.

Authors:  M Narita; J Goji; H Nakamura; K Sano
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

7.  Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources.

Authors:  Koichi Sato; Enkhzol Malchinkhuu; Takeshi Muraki; Koichi Ishikawa; Kensuke Hayashi; Masahiko Tosaka; Akikazu Mochiduki; Kinji Inoue; Hideaki Tomura; Chihiro Mogi; Hiromi Nochi; Koichi Tamoto; Fumikazu Okajima
Journal:  J Neurochem       Date:  2005-02       Impact factor: 5.372

Review 8.  Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease.

Authors:  Jameel Dennis; Luciana Nogaroli; Babette Fuss
Journal:  J Neurosci Res       Date:  2005-12-15       Impact factor: 4.164

9.  Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal.

Authors:  Gilles Ferry; Adeline Giganti; Francis Cogé; Fabien Bertaux; Kader Thiam; Jean A Boutin
Journal:  FEBS Lett       Date:  2007-07-03       Impact factor: 4.124

10.  Expression, regulation and function of autotaxin in thyroid carcinomas.

Authors:  Astrid Kehlen; Nadine Englert; Anja Seifert; Thomas Klonisch; Henning Dralle; Jürgen Langner; Cuong Hoang-Vu
Journal:  Int J Cancer       Date:  2004-05-10       Impact factor: 7.396

View more
  36 in total

1.  CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxia.

Authors:  Katie Dorman; Zhongyi Shen; Caimei Yang; Shereen Ezzat; Sylvia L Asa
Journal:  Mol Endocrinol       Date:  2012-02-02

2.  Depot-specific regulation of autotaxin with obesity in human adipose tissue.

Authors:  Chloé Rancoule; Rodolphe Dusaulcy; Karine Tréguer; Sandra Grès; Charlotte Guigné; Didier Quilliot; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Physiol Biochem       Date:  2012-05-27       Impact factor: 4.158

Review 3.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

4.  Lysophosphatidic acid can support the formation of membranous structures and an increase in MBP mRNA levels in differentiating oligodendrocytes.

Authors:  Luciana Nogaroli; Larra M Yuelling; Jameel Dennis; Karen Gorse; Shawn G Payne; Babette Fuss
Journal:  Neurochem Res       Date:  2008-07-02       Impact factor: 3.996

Review 5.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

6.  Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer.

Authors:  Rachael R Schulte; Amanda G Linkous; Dennis E Hallahan; Eugenia M Yazlovitskaya
Journal:  Cancer Lett       Date:  2011-05-28       Impact factor: 8.679

7.  Immunohistochemical detection of autotaxin (ATX)/lysophospholipase D (lysoPLD) in submucosal invasive colorectal cancer.

Authors:  Shinsuke Kazama; Joji Kitayama; Junken Aoki; Ken Mori; Hirokazu Nagawa
Journal:  J Gastrointest Cancer       Date:  2011-12

Review 8.  Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy.

Authors:  Jeffrey M Craft; Dennis Hallahan
Journal:  Future Med Chem       Date:  2011-05       Impact factor: 3.808

Review 9.  Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.

Authors:  Ponugoti Vasantha Rao
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-27       Impact factor: 2.671

Review 10.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.